Kiora Pharmaceuticals, Inc. (KPRX) vs Tvardi Therapeutics, Inc. (TVRD)

A side-by-side comparison of Kiora Pharmaceuticals, Inc. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Kiora Pharmaceuticals, Inc. logo
KPRX
Kiora Pharmaceuticals, Inc.
$11M
$2.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Tvardi Therapeutics, Inc. logo
TVRD
Tvardi Therapeutics, Inc.
$10M
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — KPRX vs TVRD

growth of $100 · dividends reinvested · last 1y
KPRX -4.9% (-4.9%/yr)TVRD -76.7% (-76.7%/yr)KPRX compounded faster over this window
0200400600800Start $1002026$95$23
KPRX TVRD

KPRX vs TVRD: by the numbers

  • •KPRX is the larger company ($11M vs $10M market cap).

Metrics side by side

Valuation

MetricKPRXTVRD
P/B ratio0.661.21

Profitability

MetricKPRXTVRD
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-65.18%-310.94%
ROIC-59.42%-323.71%

Growth (annualized)

MetricKPRXTVRD
Total return CAGR (5Y)-67.06%N/A

Go deeper

Full KPRX analysisFull TVRD analysisInteractive comparison tool

Dig into the metrics

Kiora Pharmaceuticals ROETvardi Therapeutics ROEKiora Pharmaceuticals operating marginTvardi Therapeutics operating marginKiora Pharmaceuticals revenue growthTvardi Therapeutics revenue growthKiora Pharmaceuticals free cash flowTvardi Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.